John Edward McKnight
- Oncology top 5%
- Clinical Biochemistry top 2%
- Pharmacology top 10%
- Epidemiology
- Emergency Medicine top 5%
- Co-authors
- Jane SkeltonJanet GressMarc RubinJames W. HathornMarcia BrowneMichael ThalerD. MarshallPhilip A. Pizzo
- Topics
- Antibiotics Pharmacokinetics and Efficacy (2 papers)Neutropenia and Cancer Infections (2 papers)Immune Cell Function and Interaction (2 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologyThe American Journal of Medicine
- Partner nations
- United StatesUkraineMalaysia
In The Last Decade
John Edward McKnight
6 papers receiving 626 citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Oncology 469
- Clinical Biochemistry 259
- Pharmacology 147
- Epidemiology 119
- Emergency Medicine 108
Countries citing papers authored by John Edward McKnight
This map shows the geographic impact of John Edward McKnight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Edward McKnight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Edward McKnight more than expected).
Fields of papers citing papers by John Edward McKnight
This network shows the impact of papers produced by John Edward McKnight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Edward McKnight. The network helps show where John Edward McKnight may publish in the future.
Co-authorship network of co-authors of John Edward McKnight
This figure shows the co-authorship network connecting the top 25 collaborators of John Edward McKnight. A scholar is included among the top collaborators of John Edward McKnight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Edward McKnight. John Edward McKnight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 88 | |
| 3 | Interleukin 2 and lymphokine-activated killer cell therapy: analysis of a bolus interleukin 2 and a continuous infusion interleukin 2 regimen. | 39 |
| 4 | Randomized trial of recombinant alpha 2b-interferon with or without indomethacin in patients with metastatic malignant melanoma. | 32 |
| 5 | A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and Neutropeniabreakdown → | 478 |
| 6 | 23 |
About John Edward McKnight
John Edward McKnight is a scholar working on Molecular Medicine, Oncology and Clinical Biochemistry, having authored 6 papers that have together received 661 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (2 papers), Neutropenia and Cancer Infections (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Clinical Biochemistry (259 citations), Oncology (469 citations) and Molecular Medicine (82 citations). John Edward McKnight has collaborated with scholars based in United States, Ukraine and Malaysia. Frequent co-authors include Jane Skelton, Janet Gress, Marc Rubin, James W. Hathorn, Marcia Browne, Michael Thaler, D. Marshall, Philip A. Pizzo, John Hiemenz and Robert Wesley. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.